Zentalis Pharmaceuticals, Inc. (ZNTL)
4.105
+0.34
(+8.89%)
USD |
NASDAQ |
Sep 03, 16:00
4.07
-0.04
(-0.85%)
After-Hours: 18:22
Zentalis Pharmaceuticals Net Income (Annual) : -137.06M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -137.06M |
| December 31, 2024 | -165.87M |
| December 31, 2023 | -292.30M |
| December 31, 2022 | -237.11M |
| Date | Value |
|---|---|
| December 31, 2021 | -166.09M |
| December 31, 2020 | -118.55M |
| December 31, 2019 | -46.38M |
| December 31, 2018 | -23.43M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ARS Pharmaceuticals, Inc. | -171.30M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |